Brain scans to better tell apart Alzheimer's and frontotemporal dementia
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study uses special MRI and PET scans to compare the brains of people with Alzheimer's disease, frontotemporal dementia, and healthy individuals. The goal is to better understand how these conditions affect the brain, which may help doctors tell them apart more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosed condition: Alzheimer's disease (with early-stage memory loss), frontotemporal dementia (behavioral or language changes), or be a healthy person with no memory or thinking problems.
- You must be able to safely have an MRI (no pacemaker, cochlear implant, certain metal implants, or other unsafe devices).
- You must not be very claustrophobic or unable to stay still for the scan.
- You must not have an active or poorly controlled psychiatric condition (such as severe depression or schizophrenia) or severe unstable medical illness.
- You must not have a history of severe alcohol or drug misuse within the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at testing (including brain scans) to figure out what type of frontotemporal dementia or related language/speech condition a person has. It may help by making diagnoses more accurate, which can guide better care.
This research study tracks how brain damage progresses in rare neurodegenerative diseases like frontotemporal dementia, primary progressive aphasia, PSP, CBS, and ALS. Researchers use brain imaging and tests to understand how these diseases spread in the brain, which could help develop better treatments.
This study uses brain scans (PET) to look at changes in the brain that may be related to memory problems or Alzheimer's disease. It aims to improve understanding of the disease and may help develop better treatments.
This extension study looks for predictors—measurable clues—linked to memory changes in older adults who feel their memory is worsening. You may be asked to have an amyloid PET scan, which can help researchers understand what might be driving memory concerns.
This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.
This trial uses special PET scans to see amyloid and tau proteins in the brain, which are linked to Alzheimer's. It aims to find these changes early, in people with mild memory problems or early-stage Alzheimer's.
Hear when a new FTD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.